1. Home
  2. OFS vs IRWD Comparison

OFS vs IRWD Comparison

Compare OFS & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFS
  • IRWD
  • Stock Information
  • Founded
  • OFS 2001
  • IRWD 1998
  • Country
  • OFS United States
  • IRWD United States
  • Employees
  • OFS N/A
  • IRWD N/A
  • Industry
  • OFS Finance/Investors Services
  • IRWD Biotechnology: Pharmaceutical Preparations
  • Sector
  • OFS Finance
  • IRWD Health Care
  • Exchange
  • OFS Nasdaq
  • IRWD Nasdaq
  • Market Cap
  • OFS 120.2M
  • IRWD 111.2M
  • IPO Year
  • OFS 2012
  • IRWD 2010
  • Fundamental
  • Price
  • OFS $8.23
  • IRWD $0.77
  • Analyst Decision
  • OFS
  • IRWD Buy
  • Analyst Count
  • OFS 0
  • IRWD 5
  • Target Price
  • OFS N/A
  • IRWD $4.94
  • AVG Volume (30 Days)
  • OFS 42.0K
  • IRWD 1.2M
  • Earning Date
  • OFS 07-31-2025
  • IRWD 08-11-2025
  • Dividend Yield
  • OFS 16.55%
  • IRWD N/A
  • EPS Growth
  • OFS N/A
  • IRWD N/A
  • EPS
  • OFS 0.76
  • IRWD N/A
  • Revenue
  • OFS $43,337,000.00
  • IRWD $317,676,000.00
  • Revenue This Year
  • OFS N/A
  • IRWD N/A
  • Revenue Next Year
  • OFS N/A
  • IRWD N/A
  • P/E Ratio
  • OFS $10.78
  • IRWD N/A
  • Revenue Growth
  • OFS N/A
  • IRWD N/A
  • 52 Week Low
  • OFS $7.75
  • IRWD $0.53
  • 52 Week High
  • OFS $9.80
  • IRWD $6.31
  • Technical
  • Relative Strength Index (RSI)
  • OFS 39.79
  • IRWD 47.50
  • Support Level
  • OFS $8.18
  • IRWD $0.79
  • Resistance Level
  • OFS $8.55
  • IRWD $0.95
  • Average True Range (ATR)
  • OFS 0.18
  • IRWD 0.08
  • MACD
  • OFS -0.02
  • IRWD -0.01
  • Stochastic Oscillator
  • OFS 10.98
  • IRWD 21.12

About OFS OFS Capital Corporation

OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: